Who Is Ablation Suitable For in Benign Thyroid Nodules?

Thyroid nodules are very common and the great majority are benign. Not everyone with a nodule needs treatment; most nodules sit quietly for years without causing any complaint and are simply followed with ultrasound.

The decision to treat is made by weighing the ultrasound appearance and the biopsy result together with the patient’s symptoms. "There is a nodule, so let us do something" is not the right approach — where there is no symptom or finding that would change the outcome, monitoring is itself a treatment decision.

In ablation, the nodule tissue is inactivated by controlled heating with radiofrequency or microwave energy, delivered through a thin needle-electrode placed under ultrasound guidance. There is no incision, no stitches and no general anaesthesia; the procedure is performed under local anaesthesia while you are awake.

The aim is not to "erase" the nodule but to let the inactivated tissue shrink gradually over months, easing pressure and cosmetic complaints. The healthy thyroid tissue outside the nodule is preserved.

The first and indispensable condition is that the nodule has been shown to be benign by fine-needle biopsy. In international practice this is usually confirmed with two separate biopsies; if the ultrasound shows suspicious features or there is a family history of thyroid cancer, the assessment is made even more carefully.

The second criterion is symptoms: visible swelling in the neck, a sense of pressure on swallowing, voice change or cosmetic discomfort. There is no absolute size threshold — larger nodules are treated more often because they cause complaints more often, but a small nodule may also be considered if its location causes symptoms.

Ablation may also be considered in selected cases of overactive (toxic) nodules. There, the very aim is to reduce excess hormone production, so hormone levels are followed after the procedure.

Nodules that cause no symptoms and remain stable on follow-up. Treating these brings no benefit.

Suspicious or malignant nodules. Ablation is not the standard treatment for thyroid cancer; such cases follow a different plan involving surgical and oncological assessment.

Pregnancy and breastfeeding, and situations where the patient’s general condition is not suitable, are assessed separately. Eligibility is decided by reading the ultrasound findings, the biopsy result and the hormone values together — alongside the endocrinology opinion.

Current international guidelines tie the treatment decision to the complaints a nodule causes rather than to its size. In practice, nodules larger than two centimetres are treated more often, because a growing nodule produces a more visible fullness in the neck and greater pressure.

Even so, there is no absolute size threshold. A small nodule may warrant treatment if its position makes swallowing difficult, affects the voice, or if it produces excess hormone. Conversely, a large nodule causing no complaints at all may be kept under surveillance.

In most patients treatment is completed in a single session. A second session may be planned for very high-volume nodules, or when part of the nodule extends down towards the chest.

A second session is not a sign of failure; in high-volume nodules it is a possibility anticipated from the outset and discussed with the patient in advance.

Yes. Nodules whose content is largely fluid (cystic) usually shrink faster; in these, draining the fluid and then performing ethanol ablation is an established approach.

In solid nodules the reduction proceeds more slowly and some patients may need an additional session. In mixed nodules the fluid component is addressed first, and thermal ablation is then considered for the remaining solid part.

The outcome of ablation is judged by the reduction in nodule volume and the improvement in complaints over the months after the procedure. The nodule does not disappear at once; shrinkage is gradual and generally settles towards the end of the first year.

Having the follow-up ultrasound performed, where possible, by the radiologist who did the procedure and compared against the pre-procedure images makes the assessment more reliable. At each check both the volume and the appearance of the remaining tissue are recorded.

The procedure usually takes between half an hour and an hour. You may feel warmth and pressure in the neck; additional anaesthesia is given whenever you feel uncomfortable. Your physician talks with you throughout to check your voice at intervals — being awake is part of the safety. After a short observation you go home the same day.

Setting expectations correctly matters: the nodule does not disappear at once. Shrinkage is gradual over months and is followed with ultrasound; check-ups are usually planned at 1, 3, 6 and 12 months. Large nodules may need a second session for sufficient shrinkage, and a small residue can grow again over the years — which is why regular follow-up is part of the treatment.

In ablation of benign nodules the healthy tissue outside the nodule is preserved, so thyroid hormone balance is usually unaffected and no medication is needed. This is also where it differs from surgery: because no tissue is removed, no pathological examination is possible — hence the biopsy beforehand is essential.

Thyroid ablation requires a thorough command of neck anatomy and ultrasound assessment. The nerve that supplies the vocal cord lies very close to the thyroid; keeping the needle tip continuously visible on ultrasound and, where needed, creating a safety margin by instilling fluid between neighbouring structures (hydrodissection) are therefore part of the technique.

International guidelines emphasise the same point: the physician performing the procedure is expected to be experienced in thyroid ultrasound and thyroid fine-needle biopsy, and able to assess the risk of both benign and malignant nodules. Correct patient selection and correct technique are the two factors that determine the outcome.

Some guidelines put numbers to that expectation. The 2024 Chinese guideline on ultrasound-guided thermal ablation of thyroid nodules expects the operator to have more than three years of thyroid ultrasound experience, more than two hundred ultrasound-guided thyroid biopsies, and the ability to keep the needle tip continuously visible on ultrasound throughout the procedure. This criterion is sometimes quoted as if it came from the American Thyroid Association; its source is the Chinese guideline named here.